Drug-induced lupus erythematosus overview

Revision as of 18:43, 22 June 2016 by Luke Rusowicz-Orazem (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Drug-induced lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Drug-induced lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Drug-induced lupus erythematosus overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Drug-induced lupus erythematosus overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Drug-induced lupus erythematosus overview

CDC on Drug-induced lupus erythematosus overview

Drug-induced lupus erythematosus overview in the news

Blogs on Drug-induced lupus erythematosus overview

Directions to Hospitals Treating Drug-induced lupus erythematosus

Risk calculators and risk factors for Drug-induced lupus erythematosus overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Drug-induced lupus erythematosus (DIL or DILE) is an autoimmune disorder, similar to systemic lupus erythematosus (SLE), which is induced by chronic use of certain drugs. These drugs cause an autoimmune response (the body attacks its own cells) producing symptoms similar to those of SLE. There are 38 known medications to cause DIL but there are three that report the highest number of cases: hydralazine, procainamide, and isoniazid.[1] While the criteria for diagnosing DIL has not been thoroughly established, symptoms of DIL include fever, elevated blood pressure, skin lesions, and arthritis. Generally, the symptoms recede after discontinuing use of the drugs.[2]

[Note the term "generally." There are reported cases of DIL that do not go away completely after the offending drug is removed.]

While this may not be a prevailing illness in this age of heritable and non-transmittable diseases, research on drug-induced lupus could lead to a greater understanding on the immune system. This greater understanding of our immune systems could lead to breakthroughs in many other diseases such as HIV, influenza, and other communicable diseases. Research on this topic also has pharmaceutical implications as to avoid immune reactions from future drugs.

Historical Perspective

Pathophysiology

Causes

Differentiating Drug-Induced Lupus Erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

References

  1. Rubin, Robert L. (February 4, 2005). "Drug-Induced Lupus Erythematosus". Lupus Foundation of America. Retrieved 2006-11-03.
  2. Schur, Peter H. (ed.) (1983). The Clinical Management of Systemic Lupus Erythematosus. New York: Grune & Stratton. pp. p. 221. ISBN 0-8089-1543-6. Unknown parameter |coauthors= ignored (help); Unknown parameter |month= ignored (help)


Template:WikiDoc Sources